Carlsmed (CARL) Other financing activities (2024 - 2026)

Carlsmed (CARL) has reported Other financing activities for 3 consecutive years, with $36000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities fell 98.42% year-over-year to $36000.0; the trailing twelve-month figure through Jun 2026 stood at $91.3 million (up 3333.21% YoY), and the FY2025 full-year result was $93.5 million, up 274797.06% from the prior year.
• Other financing activities slipped to $36000.0 in Q2 2026 per CARL's latest filing, from $436000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $90.8 million in Q3 2025 and bottomed at $4000.0 in Q3 2024.
• Historically, Other financing activities has averaged $13.4 million across 3 years, with a median of $368000.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Other financing activities soared 2270325.0% in 2025, then slumped 98.42% in 2026.
• Over 3 years, Other financing activities stood at $7000.0 in 2024, then soared by 1297285.71% to $90.8 million in 2025, then plunged by 99.96% to $36000.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $36000.0, $436000.0, and $90.8 million for Q2 2026, Q1 2026, and Q3 2025 respectively.